NSE ScannerComparison · NSE · data 2026-11-01
Curis Lifesciences Limited vs Medico Remedies Ltd.
In plain words
Size: Medico Remedies Ltd. is about 1.1 times the market value of Curis Lifesciences Limited.
Valuation (P/E): Curis Lifesciences Limited 21.2 vs Medico Remedies Ltd. 11.2.
Return on equity: Curis Lifesciences Limited 21.7% vs Medico Remedies Ltd. 19%.
Profit growth over 3 years: Curis Lifesciences Limited 78% a year vs Medico Remedies Ltd. 21.9% a year.
Debt to equity: Curis Lifesciences Limited 0.46 vs Medico Remedies Ltd. 0.26.
Differences in the numbers, not a recommendation of either stock.
Side by side
| CURIS | MEDICO | |
|---|---|---|
| Price | ₹180 | ₹18.61 |
| Market cap | ₹146 cr | ₹155 cr |
| P/E | 21.2 | 11.2 |
| P/B | 3.1 | — |
| ROE | 21.7% | 19.0% |
| ROCE | 26.6% | 20.4% |
| Debt / equity | 0.46 | 0.26 |
| Operating margin | 17.2% | 6.1% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 19.6% | 13.4% |
| Profit growth, 3 years (yearly) | 78.0% | 21.9% |
| 1-year return | 23.2% | -61.3% |
| Revenue, last 12 months | ₹61 cr | ₹238 cr |
| Net profit, last 12 months | ₹7 cr | ₹14 cr |
| Latest quarter | — | Jun 2026 |
| Quarter net profit | — | ₹3 cr |
| Quarter profit vs a year earlier | — | +38.5% |
| Promoter holding | — | 61.38% |
| Health check | Strong (8.5/10) | Strong (6.8/10) |
Common questions
Which has a higher P/E, Curis Lifesciences Limited or Medico Remedies Ltd.?
Curis Lifesciences Limited trades at the higher P/E (21.2 against 11.2). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Curis Lifesciences Limited (21.7% against 19.0%).
Which carries more debt?
Curis Lifesciences Limited has the higher debt-to-equity ratio (0.46 against 0.26).